MUC1 mucin is normally expressed by secretory epithelial cells but has been implicated as a tumor antigen for various vaccine immunotherapeutic studies targeting the generation of B and T cell responses because it is abundantly expressed in aberrant forms by a number of adenocarcinoma tumor cells (8). Here, MUC5AC is linked to neoplasm.